SecBot SecBot
PRESS-RELEASE ·Filed Nov 3, 2026

RXST

RxSight, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed7d 2h ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

Monitor next quarter for evidence that the commercial restructuring and Alcon collaboration stabilize or reverse the revenue decline. The widened net loss and margin compression suggest ongoing competitive pressure.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

RxSight reported Q3 2026 total revenue of $24.6M, down 19% YoY from $30.3M and missing the $27.2M consensus. GAAP net loss widened to $(0.39) per share from $(0.24), while adjusted net loss was $(0.21) per share versus consensus of $(0.19). The company highlighted commercial restructuring and the Alcon collaboration, but the top-line decline and wider losses are the dominant signals.

Key Financial Metrics

EPS (Adj.)
−$0.21
est −$0.19 · -10.5% · GAAP: $-0.39
Revenue
$24.6M
est $27.2M · -9.6% · -19.0% YoY
Rating
miss
Gross Margin
73.6%

Key Facts

  • Total revenue $24.6M, down 19% YoY from $30.3M, missing $27.2M consensus
  • GAAP net loss $(0.39) per share vs $(0.24) in Q3 2025
  • Adjusted net loss $(0.21) per share vs consensus $(0.19)
  • Gross margin contracted to 73.6% from 79.9% due to higher inventory reserves and costs
  • Cash and investments $254.7M including $60M from Alcon collaboration
  • Net loss widened to $(16.2)M from $(9.8)M in the prior year

Financial Impact

Revenue miss of $2.6M vs consensus; EPS miss of $(0.02) on adjusted basis; gross margin decline of 6.3pp

revenueepsgross marginnet loss

Risk Factors

  • Revenue decline of 19% YoY driven by competitive pressures
  • Gross margin contraction due to inventory reserves and higher costs
  • Widening net loss and negative adjusted earnings trajectory

Market Snapshot

Exchange
Nasdaq
Sector
Ophthalmic Goods
Analyst Consensus
7% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3394771

Track record

11 reports on RXST

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +28.44% at T+20 after the Sep 2, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 10, 2026today SC 13G Neutral 3/10 Entry $4.81 Now $4.90 +1.87% settles Nov 12
  2. Nov 3, 20267d ago 8-K Bearish 5/10 Entry $4.99 to $4.54 Now $4.90 +1.80% ▲ +9.02% +4.61% vs SPY
  3. Nov 3, 20267d ago Press Release Bearish 6/10 Viewing No price data
  4. Nov 2, 20268d ago SC 13G/A Bearish 4/10 Entry $4.59 to $4.99 Now $4.90 −6.75% ▼ −8.71% −7.06% vs SPY
  5. Oct 27, 202614d ago SC 13G/A Neutral 3/10 Entry $4.90 to $5.05 Now $4.90 +0.00% ▲ +3.06% +3.44% vs SPY
  6. Oct 27, 202614d ago SC 13G/A Neutral 3/10 Entry $4.90 to $5.05 Now $4.90 +0.00% ▲ +3.06% +3.44% vs SPY
  7. Oct 20, 202621d ago Press Release Neutral 2/10 Entry $4.90 to $5.08 Now $4.90 +0.00% ▲ +3.67% +4.85% vs SPY
  8. Sep 2, 20269w ago Insider Cluster Bearish 4/10 Entry $6.54 to $6.38 Now $4.90 +25.08% ▲ +2.52% +2.14% vs SPY
  9. Sep 2, 20269w ago Insider Cluster Neutral 3/10 Entry $6.54 to $6.38 Now $4.90 −25.08% ▼ −2.52% −2.14% vs SPY
  10. Apr 22, 202628w ago Press Release Neutral 1/10 Entry $7.20 to $7.25 Now $4.90 −31.94% ▲ +0.69% −0.09% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026